[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355882-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355882-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lipid-metabolism-as-a-central-driver-of-immune-remodeling-and-therapeutic-vulnerability-in-metastatic-colorectal-cancer","Lipid metabolism as a central driver of immune remodeling and therapeutic vulnerability in metastatic colorectal cancer","","Dysregulated lipid metabolism defines colorectal cancer progression, especially metastatic disease, where metabolic adaptation and immune evasion are tightly linked across murine models and human studies. Alterations in lipid synthesis, uptake, transport, and oxidation sustain tumor bioenergetics while actively reshaping the tumor immune microenvironment. Regulators such as FASN, SREBP, CD36-mediated uptake, cholesterol metabolism, and fatty-acid oxidation coordinate oncogenic signaling and promote immunosuppression featuring T-cell exhaustion, macrophage polarization, and ferroptosis resistance. Multiomics tools map lipid-dependent immune niches and uncover therapeutic vulnerabilities, enabling lipid-pathway targeting and synergy with immunotherapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lipid-metabolism-as-a-central-driver-of-immune-remodeling-and-therapeutic-vulnerability-in-metastatic-colorectal-cancer/355882/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lipid-metabolism-as-a-central-driver-of-immune-remodeling-and-therapeutic-vulnerability-in-metastatic-colorectal-cancer/355882.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does dysregulated lipid metabolism contribute to metastatic colorectal cancer progression?","Question",{"text":63,"@type":64},"It sustains tumor bioenergetics and actively remodels the tumor immune microenvironment, supporting immune evasion and progression in metastatic disease.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which lipid metabolic regulators are highlighted as key coordinators?",{"text":68,"@type":64},"The review emphasizes regulators including FASN, SREBP signaling, CD36-mediated lipid uptake, cholesterol metabolism, and fatty acid oxidation.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic opportunities does the article propose?",{"text":72,"@type":64},"Therapeutic strategies targeting lipid metabolic pathways may exploit newly identified metabolic vulnerabilities and potentially synergize with immunotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355882,1790188758,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Shang et al. Lipids in Health and Disease (2026) 25:154 Lipids in Health and Disease  \n[https://doi.org/10.1186/s12944-026-02956-9](https://doi.org/10.1186/s12944-026-02956-9)  \nREVIEW Open Access  \nLipid metabolism as a central driver of immune remodeling and therapeutic vulnerability in metastatic colorectal cancer  \nYuru Shang1†, Qingxi Yang2†, Runlin Zhang3†, Weiguo Xu3,4, A. M. Abd El-Aty5,6, Yu Gao7* and Tianbao Wang1*  \nAbstract  \nDysregulated lipid metabolism has emerged as a defining hallmark of colorectal cancer (CRC) progression, particularly in metastatic disease, where metabolic adaptation and immune evasion are tightly interconnected, as demonstrated in both murine models and human studies. Increasing evidence has demonstrated that alterationsin lipid synthesis, uptake, transport, and oxidation not only sustain tumor bioenergetics but also actively remodel the tumor immune microenvironment. Key lipid metabolic regulators—including FASN, SREBP signaling, CD36-mediated lipid uptake, cholesterol metabolism, and fatty acid oxidation—coordinate oncogenic signaling and promote immunosuppressive states characterized by T-cell exhaustion, macrophage polarization, and ferroptosis resistance, on the basis largely of correlative and preclinical evidence. Recent advances in multiomics technologies, including single-cell and spatial transcriptomics, metabolomics, and lipidomics, have enabled high-resolution mapping of lipid-dependent immune niches within metastatic CRC (mCRC) lesions. These approaches reveal lipid metabolism as a central organizer of tumor–immune interactions and identify previously unrecognized metabolic vulnerabilities. In this review, we integrate current knowledge on lipid metabolic reprogramming in CRC with emerging multiomics insights, highlighting the mechanisms linking lipid metabolism, ferroptosis, gut microbiota interactions, and immune remodeling. We further discuss therapeutic strategies targeting lipid metabolic pathways and their potential synergy with immunotherapy. Collectively, the results of this work suggest that understanding lipid metabolism is a unifying framework for understanding mCRC biology and developing metabolism-guided therapeutic interventions.  \nKeywords Lipid metabolism, Colorectal cancer, Tumor immune microenvironment  \n†Yuru Shang, Qingxi Yang and Runlin Zhang contributed equally to this work as co-first authors.  \n*Correspondence: Yu Gao[ggyy572216@163.com](ggyy572216@163.com)[ ](ggyy572216@163.com)Tianbao Wang [wangtianbao1@163.com](wangtianbao1@163.com)  \n1Department of Gastrointestinal Surgery South China Hospital, Medical School & Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, NationalRegional Key Technology Engineering Laboratory for Medical Ultrasound,  \nShenzhen University, Shenzhen University Medical School,  \nShenzhen 518060, China  \n2Department of Oncology, Shandong Provincial Taishan Hospital,  \nTaian 271000, China  \n3Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan 250355, China 4Institute of Alternative Medicine, Leverkusen 5651373, Germany 5Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum 25240, Turkey  \n6Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt  \n7Department of Oncology, Shanxi Provincial Academy of Traditional Chinese Medicine, Taiyuan 030000, China  \n© The Author(s) 2026, modified publication 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the ar","cbCaibxRjmQToDVU","https://ap.wps.com/l/cbCaibxRjmQToDVU","pdf",2154459,23,"English","# Abstract\n## Keywords\n# Introduction\n## Colorectal cancer burden and genetics\n## Lipid metabolism as a hallmark of progression\n## Tumor microenvironment remodeling","[{\"question\":\"How does dysregulated lipid metabolism contribute to metastatic colorectal cancer progression?\",\"answer\":\"It sustains tumor bioenergetics and actively remodels the tumor immune microenvironment, supporting immune evasion and progression in metastatic disease.\"},{\"question\":\"Which lipid metabolic regulators are highlighted as key coordinators?\",\"answer\":\"The review emphasizes regulators including FASN, SREBP signaling, CD36-mediated lipid uptake, cholesterol metabolism, and fatty acid oxidation.\"},{\"question\":\"What therapeutic opportunities does the article propose?\",\"answer\":\"Therapeutic strategies targeting lipid metabolic pathways may exploit newly identified metabolic vulnerabilities and potentially synergize with immunotherapy.\"}]","Lipid metabolism as a central driver of immune remodeling and therapeutic vulnerability in metastatic colorectal cancer | PDF",1790121510,58,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d02bb16a0ac8bda9dee115c84e753ad.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8110ab3e5af838f82d0ef97ca4c0fe3d.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b02be59054e868406ec4158d8ee03540.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2f1910b166a93716a07d2f591fc2068.webp",980,1306]